Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AEMDNASDAQ:DRIONASDAQ:IINNNASDAQ:OSRH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAEMDAethlon Medical$1.76-10.7%$2.92$1.75▼$8.44$3.54M1.89215,482 shs65,078 shsDRIODarioHealth$0.67-4.5%$0.70$0.50▼$1.55$29.61M1.58283,479 shs265,349 shsIINNInspira Technologies Oxy B.H.N.$0.73-8.1%$0.59$0.40▼$2.02$9.16M2.12483,466 shs256,235 shsOSRHOSR$1.41-13.5%$1.34$1.02▼$13.40$27.18M1.612.67 million shs99,700 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAEMDAethlon Medical-2.48%-27.04%-40.55%-34.09%-52.88%DRIODarioHealth-3.13%-0.36%-3.30%+4.76%-39.35%IINNInspira Technologies Oxy B.H.N.-1.13%+5.33%+41.07%+8.23%-60.89%OSRHOSR+1.24%+16.43%+34.71%+13.59%+162,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAEMDAethlon Medical3.1101 of 5 stars3.55.00.00.02.50.01.3DRIODarioHealth1.6863 of 5 stars3.30.00.00.02.20.81.3IINNInspira Technologies Oxy B.H.N.2.2556 of 5 stars3.53.00.00.02.41.70.0OSRHOSRN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAEMDAethlon Medical 3.00Buy$56.003,081.82% UpsideDRIODarioHealth 2.67Moderate Buy$2.00200.30% UpsideIINNInspira Technologies Oxy B.H.N. 3.00Buy$2.00175.52% UpsideOSRHOSR 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest IINN, OSRH, AEMD, and DRIO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/2/2025IINNInspira Technologies Oxy B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy6/2/2025IINNInspira Technologies Oxy B.H.N.Litchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy$2.005/19/2025DRIODarioHealthLitchfield Hills ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$3.00(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAEMDAethlon Medical$570K6.21N/AN/A$2.19 per share0.80DRIODarioHealth$28.03M1.06N/AN/A$2.14 per share0.31IINNInspira Technologies Oxy B.H.N.N/AN/AN/AN/A$0.45 per shareN/AOSRHOSR-$148.95K-182.48N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAEMDAethlon Medical-$12.21M-$12.64N/AN/AN/AN/A-153.96%-109.13%6/26/2025 (Estimated)DRIODarioHealth-$59.43M-$0.56N/AN/AN/A-205.62%-72.16%-40.74%8/6/2025 (Estimated)IINNInspira Technologies Oxy B.H.N.-$11.29MN/A0.00∞N/AN/AN/AN/AN/AOSRHOSRN/AN/A0.00∞N/AN/AN/AN/AN/ALatest IINN, OSRH, AEMD, and DRIO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/26/2025Q4 2025AEMDAethlon Medical-$0.13N/AN/AN/AN/AN/A5/20/2025Q1 2025OSRHOSRN/A-$1.04N/A-$1.04N/A$0.76 million5/14/2025Q1 2025DRIODarioHealth-$0.07-$0.14-$0.07-$0.14$7.48 million$6.75 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAEMDAethlon MedicalN/AN/AN/AN/AN/ADRIODarioHealthN/AN/AN/AN/AN/AIINNInspira Technologies Oxy B.H.N.N/AN/AN/AN/AN/AOSRHOSRN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAEMDAethlon MedicalN/A2.802.80DRIODarioHealth0.351.571.32IINNInspira Technologies Oxy B.H.N.0.092.232.13OSRHOSRN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAEMDAethlon Medical1.99%DRIODarioHealth33.39%IINNInspira Technologies Oxy B.H.N.12.72%OSRHOSR55.30%Insider OwnershipCompanyInsider OwnershipAEMDAethlon Medical1.20%DRIODarioHealth11.20%IINNInspira Technologies Oxy B.H.N.29.40%OSRHOSR33.67%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAEMDAethlon Medical102.01 million14.30 millionNo DataDRIODarioHealth20044.46 million28.47 millionOptionableIINNInspira Technologies Oxy B.H.N.2012.62 million8.91 millionNot OptionableOSRHOSRN/A19.28 million2.68 millionN/AIINN, OSRH, AEMD, and DRIO HeadlinesRecent News About These CompaniesOSRH OSR Holdings, Inc.June 4, 2025 | seekingalpha.comOSRH stock touches 52-week low at $1.07 amid market challengesMay 23, 2025 | investing.comOSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH TokenMay 22, 2025 | prnewswire.comDarnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative BiologicsMay 2, 2025 | prnewswire.comDarnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment TechnologyApril 9, 2025 | prnewswire.comOSR Holdings enters $80 mln stock purchase agreement with White Lion GBM Innovation FundApril 3, 2025 | msn.comOSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma TherapiesApril 3, 2025 | prnewswire.comDriving the Future of Healthcare HIT, OSRH, THTX, LPTX, CSDX, Innovations in Health Insurance, Virtual Care, Oncology, and Chronic Disease TreatmentMarch 28, 2025 | insurancenewsnet.comOSR Holdings Inc.: Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in GlioblastomaMarch 26, 2025 | finanznachrichten.deOSR Holdings Inc.: OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific OfficerMarch 26, 2025 | finanznachrichten.deOSR Holdings Inc OSRHMarch 26, 2025 | morningstar.comVaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in GlioblastomaMarch 26, 2025 | prnewswire.comOSR Holdings Appoints Dr. Constance Höfer as Chief Scientific OfficerMarch 25, 2025 | prnewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeIINN, OSRH, AEMD, and DRIO Company DescriptionsAethlon Medical NASDAQ:AEMD$1.76 -0.21 (-10.66%) Closing price 04:00 PM EasternExtended Trading$1.80 +0.03 (+1.99%) As of 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation. The company was incorporated in 1999 and is based in San Diego, California.DarioHealth NASDAQ:DRIO$0.67 -0.03 (-4.52%) Closing price 04:00 PM EasternExtended Trading$0.70 +0.03 (+5.11%) As of 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems. It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.Inspira Technologies Oxy B.H.N. NASDAQ:IINN$0.73 -0.06 (-8.11%) Closing price 04:00 PM EasternExtended Trading$0.73 +0.00 (+0.01%) As of 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira Technologies Oxy B.H.N. Ltd. was incorporated in 2018 and is headquartered in Ra'annana, Israel.OSR NASDAQ:OSRH$1.41 -0.22 (-13.50%) As of 03:59 PM EasternOSR Holdings leverages its international network of partners in the US, Europe, and South Korea to market and license its pipeline of proprietary platform technologies for broad application to efficient clinical trial programs, with the ultimate goal of addressing unmet medical needs. We partner with biotherapeutics companies with innovative and proprietary drug R&D "platform technologies" versus "assets only" companies, whose commercial viability is heavily dependent on positive results for individual treatment modalities in extremely rigorous and time consuming clinical trials. We focus on value creation through investments and collaborations with US and EU biotech companies, with the strategic goal of expansion into South Korea (specifically) and Asia (generally). OSR Holdings is headquartered in Paju, South Korea. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Ignore the Noise—Samsara Stock Is Still a Strong Buy Fastenal Stock After Split: Poised for 5 More Years of Gains Analysts Love Lovesac, But Investors Should Be Cautious Oracle’s Cloud Boom Is Just Getting Started Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
